Lung Cancer News and Research

Latest Lung Cancer News and Research

Regular use of aspirin significantly reduces overall cancer risk

An analysis of data from two major, long-term epidemiologic studies finds that the regular use of aspirin significantly reduces the overall risk of cancer, a reduction that primarily reflects a lower risk of colorectal cancer and other tumors of the gastrointestinal tract.

4 Mar 2016

Twitter may be effective, untapped resource to boost patient enrollment in cancer clinical trials

Twitter may be an effective, untapped resource to stimulate interest in cancer clinical trials and boost enrollment, physicians at the Abramson Cancer Center of the University of Pennsylvania suggest in a new research letter in JAMA Oncology. Analyzing thousands of lung cancer tweets on the social media site revealed that a surprisingly large number were about clinical trials, particularly ones on immunotherapy, although none were used for recruitment.

4 Mar 2016

Differences in certain type of small protein may shed light on lung cancer risk in different races

Research from an investigator at Rutgers Cancer Institute of New Jersey and colleagues from the National Cancer Institute and other facilities, shows differences in a certain type of small protein vary by race and may contribute differently to the development of lung cancer in African Americans and European Americans.

3 Mar 2016

Rice university researchers uncover elusive lung cancer cells

Researchers at Rice University and the University of Texas MD Anderson Cancer Center have uncovered a trick used by lung cancer cells to hide from the body's immune system.

3 Mar 2016

Oncimmune partners with Stroke Detection Plus to offer EarlyCDT-Lung test

Oncimmune, a leader in early cancer detection, today announced a partnership with Stroke Detection Plus® (SDP), a leading provider of cardiovascular and corporate wellness screenings in the US. Stroke Detection Plus and its wellness division, Health Gauge, will offer Oncimmune's EarlyCDT-Lung test to its clients which include large employers, unions and individuals.

3 Mar 2016

Researchers aim to develop gentler treatment that 'tricks' cancer cells

The most common treatments for cancer are radiation and chemotherapy. However they have side effects and also damage healthy tissues. Moreover, their effectiveness is limited when the cancer has spread through out the body. Researchers at the Niels Bohr Institute are therefore working to develop a gentler treatment that 'tricks' the cancer cells, which would absorb a cytotoxin and therefore be destroyed, while healthy cells would remain unaffected. The results are published in the scientific journal, Scientific Reports.

2 Mar 2016

Research unveils standard front-line treatment for advanced ovarian cancer

Research led by a Dignity Health St. Joseph's Hospital and Medical Center physician on ovarian cancer was published in the Feb. 24, 2016 issue of New England Journal of Medicine. The research was directed by Bradley J. Monk, M.D. and researchers at 12 other medical facilities around the nation.

27 Feb 2016

New 3-D microscope allows researchers to look at living cancer cells in controlled microenvironment

UT Southwestern Medical Center researchers have designed and built a microscope capable of creating high-resolution, 3-D images of living cancer cells in realistic, controllable microenvironments.

27 Feb 2016

Light reflectance spectroscopy may lead to real-time tissue analysis during prostate cancer surgery

Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time tissue analysis during prostate cancer surgery.

27 Feb 2016

UCLA researchers pioneer more effective approach to improve cancer treatment

Despite a growing interest in developing non-invasive methods to identify rare cancer cells or cancer cell DNA in blood, current techniques remain complicated and often prohibitively expensive. Now, UCLA researchers have pioneered a more effective approach to these "liquid biopsies" that has the potential to offer a streamlined and low-cost solution for people with the disease.

23 Feb 2016

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.

23 Feb 2016

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.

23 Feb 2016

Sanford Health clinical trial testing effectiveness of investigational cancer drug nivolumab

People with Merkel cell, gynecological, gastric and head and neck cancers may be eligible to participate in a clinical trial at Sanford Health testing the effectiveness of an investigational drug called nivolumab.

18 Feb 2016

New drug combination shows promise for patients with non-small cell lung cancer

Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. With a 5-year survival rate at only 18 percent, the development of new and improved treatment options is needed.

18 Feb 2016

Autoantibodies can potentially detect lung cancer at early stage

Preliminary research has identified autoantibodies, immune proteins found in the blood specific for one's own proteins, that can potentially detect lung cancer early by distinguishing between smokers with or without lung cancer and also discriminate between lung cancer and low-dose computed tomography (LDCT) detected non-cancerous lung lesions.

18 Feb 2016

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announce that they have entered into distribution, license and supply agreements with Mundipharma and its network of independent associated companies granting exclusive rights to anamorelin in Norway, Finland, Sweden, Denmark and Iceland.

16 Feb 2016

Wake Forest Baptist researchers develop new nanotechnology to detect disease biomarkers

Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.

15 Feb 2016

Household and outdoor air pollution kills more than 5.5 million people every year

New research shows that more than 5.5 million people die prematurely every year due to household and outdoor air pollution. More than half of deaths occur in two of the world's fastest growing economies, China and India.

15 Feb 2016

GWAS can help pinpoint genetic variants that predict lifestyle risks for diseases

Genome wide association studies (GWAS) scan the entire genome in order to pinpoint genetic variants associated with a particular disease. The technique is employed to identify biological pathways - the series of actions and changes that have occurred in cells and genetic material - that can be linked to the causation of a disease.

15 Feb 2016

CNIO researchers reveal how combination of dasatinib and demcizumab reduces lung adenocarcinomas

Lung cancer is one of the most prevalent types of cancer, with more than 20,000 new cases diagnosed each year in Spain. Lung adenocarcinomas carrying oncogenic KRAS, the engine driving these tumours in 30% of cases, constitute the most aggressive sub-type because, unlike other types of lung cancer, there are no targeted therapies beyond the standard cisplatin-based treatment.

12 Feb 2016

Lung Cancer News and Research

Latest Lung Cancer News and Research

Regular use of aspirin significantly reduces overall cancer risk

Twitter may be effective, untapped resource to boost patient enrollment in cancer clinical trials

Differences in certain type of small protein may shed light on lung cancer risk in different races

Rice university researchers uncover elusive lung cancer cells

Oncimmune partners with Stroke Detection Plus to offer EarlyCDT-Lung test

Researchers aim to develop gentler treatment that 'tricks' cancer cells

Research unveils standard front-line treatment for advanced ovarian cancer

New 3-D microscope allows researchers to look at living cancer cells in controlled microenvironment

Light reflectance spectroscopy may lead to real-time tissue analysis during prostate cancer surgery

UCLA researchers pioneer more effective approach to improve cancer treatment

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

Sanford Health clinical trial testing effectiveness of investigational cancer drug nivolumab

New drug combination shows promise for patients with non-small cell lung cancer

Autoantibodies can potentially detect lung cancer at early stage

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Wake Forest Baptist researchers develop new nanotechnology to detect disease biomarkers

Household and outdoor air pollution kills more than 5.5 million people every year

GWAS can help pinpoint genetic variants that predict lifestyle risks for diseases

CNIO researchers reveal how combination of dasatinib and demcizumab reduces lung adenocarcinomas

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in